default author photo

Irina Kislaya

National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department

Lisbon

Portugal

SCHOLARLY PAPERS

2

DOWNLOADS

780

TOTAL CITATIONS

16

Scholarly Papers (2)

1.

Comparative COVID-19 Vaccines Effectiveness in Preventing Infections, Hospitalizations, and Deaths with SARS-CoV-2 BA.5 and Ba.2 Omicron Lineages: A Case-Case and Cohort Study Using Electronic Health Records in Portugal

Number of pages: 16 Posted: 03 Aug 2022
National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Directorate of Information and Analysis Services, National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, Unilabs, Algarve Biomedical Center Research Institute (ABC-RI), affiliation not provided to SSRN, Directorate of Information and Analysis Services, affiliation not provided to SSRN, National Health Institute Doutor Ricardo Jorge (INSA) - Innovation and Technology Unit, Unilabs, affiliation not provided to SSRN, affiliation not provided to SSRN, National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, affiliation not provided to SSRN, Administração Central do Sistema de Saúde, I.P., National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, Unilabs, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, National Health Institute Doutor Ricardo Jorge (INSA) - Innovation and Technology Unit, National Health Institute Doutor Ricardo Jorge (INSA) - Innovation and Technology Unit, Directorate of Information and Analysis Services, NOVA University Lisbon - NOVA National School of Public Health, National Institute of Health Doutor Ricardo Jorge and Directorate of Information and Analysis Services
Downloads 627 (105,722)
Citation 5

Abstract:

Loading...

COVID-19, relative vaccine effectiveness, post-infection vaccine effectiveness, BA5, BA2

2.

Omicron (BA.1) SARS-CoV-2 Variant Is Associated With Reduced Risk of Hospitalization and Length of Stay Compared With Delta (B.1.617.2)

Number of pages: 13 Posted: 25 Jan 2022
Directorate of Information and Analysis Services, Directorate of Information and Analysis Services, Directorate of Information and Analysis Services, Directorate of Information and Analysis Services, Directorate of Information and Analysis Services, Directorate of Information and Analysis Services, National Health Institute Doutor Ricardo Jorge (INSA) - Innovation and Technology Unit, National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, National Health Institute Doutor Ricardo Jorge (INSA) - Innovation and Technology Unit, National Health Institute Doutor Ricardo Jorge (INSA) - Innovation and Technology Unit, Unilabs, Unilabs, Unilabs, Algarve Biomedical Center Research Institute (ABC-RI), University of Algarve - Faculty of Medicine and Biomedical Sciences (FMCB), Portuguese Red Cross Laboratory, Portuguese Red Cross Laboratory, Portuguese Red Cross Laboratory, Administração Central do Sistema de Saúde, I.P., NOVA University Lisbon - NOVA National School of Public Health, NOVA University Lisbon - Public Health Research Center, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Directorate of Information and Analysis Services and NOVA University Lisbon - NOVA National School of Public Health
Downloads 153 (485,678)
Citation 11

Abstract:

Loading...

COVID-19, SARS-CoV-2, hospitalization, Omicron, BA.1, Delta, B.1.617.2, severity